Stockreport

Dianthus Therapeutics to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026

Dianthus Therapeutics, Inc.  (DNTH) 
PDF NEW YORK and WALTHAM, Mass., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to developi [Read more]